About the Coalition
The World Ovarian Cancer Coalition (WOCC) is a not-for-profit organization, established in 2016, working across the globe to reduce the impact ovarian cancer has on the lives of women and their loved ones.
The creation of the World Ovarian Cancer Coalition is a logical and powerful next step that builds on the significant impact of the annual flagship ovarian cancer awareness campaign – World Ovarian Cancer Day.
Our mission is to ensure the best possible chance of survival, and the best quality of life for every woman with ovarian cancer – wherever she lives.
By working together on the World Ovarian Cancer Day campaign for the last five years, leaders from ovarian cancer patient advocacy organizations around the world have established, beyond a shadow of a doubt, that by working together we can:
- Achieve global collaboration in the ovarian cancer community
- Align on powerful ovarian cancer key messages
- Cross cultural and language barriers to truly create one voice for every woman
- Increase the visibility and profile of the cause
- Add value and credibility to patient organizations
Be part of the global movement: Join the World Ovarian Cancer Coalition
Sign up today to be a member of the World Ovarian Cancer Coalition. By joining the Coalition, you will be part of a vibrant and committed global ovarian cancer community. You will be able to participate in and contribute to exciting new World Ovarian Cancer Coalition projects and activities and help us make World Ovarian Cancer Day even bigger and better. Please register as one of the following:
Any patient group that is involved in the ovarian cancer advocacy movement is eligible to become a World Ovarian Cancer Coalition Partner.
Groups that are not involved in patient advocacy but support our work (for example, health care professional groups) are eligible to join as World Ovarian Cancer Coalition as Affiliates.
Individuals who support the global ovarian cancer efforts (for example, through World Ovarian Cancer Day) are welcome to join the Coalition as supporters.
Over the coming months watch for updates of the World Ovarian Cancer Coalition website to include details of our Partner and Affiliate member organizations.
Who We Are
The World Ovarian Cancer Coalition is a network of committed organizations and individuals from across the world, united in their commitment to ensure the best possible chance of survival, and the best possible quality of life for every woman with ovarian cancer – wherever they are.
The Coalition was established as a not-for-profit organization in 2016. Meet the international leadership team:
World Ovarian Cancer Coalition – Board of Directors
Elisabeth Baugh, Chair
Elisabeth Baugh’s achievements over 19 years as CEO at Ovarian Cancer Canada include merging two charities to create one voice for ovarian cancer in 2007, raising the organization to a national presence with six regional offices, development of education and awareness programs and mission oversight.
Elisabeth chaired the first-ever World Ovarian Cancer Day on May 8, 2013. This event, which she continues to lead, now boasts more than 100 organizational participants in 28 countries, and has formally become the World Ovarian Cancer Coalition, of which Elisabeth is also Chair. She is active on a number of Patient Advisory Boards globally.
Previously, Elisabeth co-founded and was Executive Director for 10 years at AboutFace, a national organisation dedicated to helping individuals with facial differences. Elisabeth has received the Order of Ontario and Queen’s Jubilee Medal and been recognized three times as one of Canada’s Top 100 Women for her achievements in the charitable sector.
“The World Ovarian Cancer Coalition’s vision is to ensure the best possible chance of survival, and the best possible quality of life for every woman with ovarian cancer – wherever they are. The task of the World Ovarian Cancer Coalition Board of Directors is to unite the ovarian cancer community across the world to make this happen. I am proud to be part of this movement and inspired by all that we work with.”
Annwen Jones, Vice-Chair
Annwen Jones is Chief Executive of Target Ovarian Cancer, the leading ovarian cancer charity in the United Kingdom. She has extensive experience in the non-profit sector, having served as Chief Executive of the Juvenile Diabetes Research Foundation, as Council member of the Association of Medical Research Charities in the UK and as Chief Executive of Ovarian Cancer Action.
Annwen holds a number of senior positions, both national and international. She is Vice-Chair of the World Ovarian Cancer Coalition, incorporating World Ovarian Cancer Day, and she has served on the Steering Committee of the European Network of Gynaecological Cancer Advocacy Groups (2014–2016). She was appointed by NHS England to the National Cancer Drugs Fund Panel in 2014.
Annwen holds a Master of Business Administration from Henley Business School.
“I was honoured to be part of the team that co-founded World Ovarian Cancer Day in 2013 because of the urgent need to raise awareness of this much-neglected cancer on a global scale. The establishment of the World Ovarian Cancer Coalition is a major step forward because I believe that by working together – speaking with a single voice 365 days of the year – we can achieve even more for woman affected by this disease.”
Calaneet Balais, Vice-Chair
Calaneet has served as Chief of Strategy at The ALS Association since June 2016. Prior to joining The ALS Association, Calaneet served as CEO of the Ovarian Cancer National Alliance. In this role, she achieved numerous accomplishments, including testifying before Congress, initiating the first ever bi-partisan Congressional Ovarian Cancer Caucus and overseeing “50 States of Teal”, a report card that called out individual states on their coverage of women’s health care implementation through the Affordable Care Act (ACA). Calaneet was instrumental in helping to create the largest global organization dedicated to ovarian cancer research, advocacy and patients, Ovarian Cancer Research Fund Alliance.
Calaneet holds an MBA from Herriot-Watt University, a Master of Science in Human Movement Science Education from the University of Memphis, and a Bachelor of Science in Exercise Science from Truman State University.
“Despite being the deadliest of all gynecological cancers, ovarian cancer it is characterized around the world by a lack awareness of symptoms and late-stage diagnosis. I am convinced that by coming together through the World Ovarian Cancer Coalition, we can do much more to raise the visibility and profile of ovarian cancer on a global scale and help make a difference for women locally.”
Robin Cohen, Board Member
Robin Cohen is the CEO and Co-Founder of the Sandy Rollman Ovarian Cancer Foundation. She is a member of the Oncology Nursing Society, the Society of Gynecologic Nurse Oncologists, Sigma Theta Tau Honor Society and the Cambridge Who’s Who. She has been recognized as one of the 75 Greatest Living Philadelphians. She has served on the board of directors of the Ovarian Cancer National Alliance for the last seven years and is now the Vice President of the Board of the Ovarian Cancer Research Fund Alliance. Robin recently joined the Board of World Ovarian Cancer Coalition.
“I am excited about being part of the World Ovarian Cancer Coalition and the opportunity to join forces with supporters from around the world to draw attention to this disease. Globally, ovarian cancer is diagnosed annually in nearly a quarter of a million women and is responsible for 140,000 deaths each year. I am part of the World Ovarian Cancer Coalition because I believe that the time has come for global action.”
Jane Hill, Board Member
Jane is CEO of Ovarian Cancer Australia, the National consumer organisation taking action for women affected by ovarian cancer. Jane is actively involved internationally in her role as member of the Board of Directors of the World Ovarian Cancer Coalition. She is also a Director of Australian think-tank, the Cancer Drugs Alliance, an organisation which is recommending changes in drug approval processes to make cancer drugs available more quickly to patients who need them. She is also one of two independent directors of the Freemasons Foundation Victoria, a philanthropic body with $50 million under investment. Jane’s ambitious goal is to increase survival rates for ovarian cancer by 25% by the year 2025.
Jane has 15 years experience in non-profit leadership and a solid grounding in strategy and risk, people leadership and governance. She is a Fellow of the Australian Institute of Company Directors and author of KPMG’s flagship publication, the Company Director’s Toolkit, a project she undertook at KPMG within the Board Advisory Services Division. Before embarking on her career in non-profit leadership, Jane studied Arts/Law, followed by an MBA, and post-graduate studies in marketing and corporate governance.
“It is both an honor and a privilege to join the World Ovarian Cancer Coalition Board of Directors. I believe that through this Coalition we have a significant opportunity to help drive global improvements for ovarian cancer on all fronts – awareness, diagnosis, treatment and quality of life. I very much look forward to working with my fellow World Ovarian Cancer Coalition Board members – and the ovarian cancer community from around the world – as we take forward this important mission on behalf of all those affected by this disease.”
The World Ovarian Cancer Coalition was established to do much more across the globe to tackle ovarian cancer. That includes highlighting the gaps in ovarian cancer treatment, as well as care and support. It also means bringing together the ovarian cancer community to support each other and build on all the good work already being done.
We have already launched an exciting new research project looking at the experiences of ovarian cancer patients – and those that support them – around the world.
Watch for updates on all the planned initiatives through this website and newsletter. Ensure that you stay informed by completing the registration to join the World Ovarian Cancer Coalition.
World Ovarian Cancer Day
World Ovarian Cancer Day provides an opportunity each year to raise awareness of this disease that takes the lives of 140,000 women per year internationally. Join us in this global movement to ensure all the women we love know about ovarian cancer.
About World Ovarian Cancer Day
Ovarian cancer has the lowest survival rate of all gynecological cancers, and is characterized around the world by a lack of awareness of symptoms and late stage diagnosis.
May 8, 2013, was the first World Ovarian Cancer Day. On this day, ovarian cancer organizations from around the world united to educate their communities about ovarian cancer and its symptoms. For women living with the disease, and their families and friends, World Ovarian Cancer Day has built, and will continue to build, a sense of solidarity in the fight against the disease.
Ovarian cancer is diagnosed annually in nearly a quarter of a million women globally, and is responsible for 140,000 deaths each year. Statistics show that just 45% of women with ovarian cancer are likely to survive for five years compared to up to 89% of women with breast cancer.
Symptoms are often misdiagnosed, as they can be confused with symptoms of other less severe illnesses, particularly gastrointestinal complaints. The majority of patients are only identified in the advanced stages when the disease becomes more difficult to treat. There is no routine, simple test to accurately detect ovarian cancer.
For more information about ovarian cancer, visit the World Ovarian Cancer Day site.